The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Paclitaxel and Docetaxel Market Research Report 2025
Synopsis
The global Paclitaxel and Docetaxel market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Paclitaxel and Docetaxel is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Paclitaxel and Docetaxel is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Paclitaxel and Docetaxel include Phyton, ScinoPharm, Novasep, Samyang, Polymed, TAPI (Teva), Fresenius-kabi, Huiang biopharma and Southpharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Paclitaxel and Docetaxel, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paclitaxel and Docetaxel.
Report Scope
The Paclitaxel and Docetaxel market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Paclitaxel and Docetaxel market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Paclitaxel and Docetaxel manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
Segment by Type
Paclitaxel
Docetaxel
Segment by Application
Ovarian Cancer
Cervical Cancer
Breast Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Paclitaxel and Docetaxel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Paclitaxel and Docetaxel in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Paclitaxel and Docetaxel market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Paclitaxel and Docetaxel is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Paclitaxel and Docetaxel is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Paclitaxel and Docetaxel include Phyton, ScinoPharm, Novasep, Samyang, Polymed, TAPI (Teva), Fresenius-kabi, Huiang biopharma and Southpharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Paclitaxel and Docetaxel, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paclitaxel and Docetaxel.
Report Scope
The Paclitaxel and Docetaxel market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Paclitaxel and Docetaxel market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Paclitaxel and Docetaxel manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
Segment by Type
Paclitaxel
Docetaxel
Segment by Application
Ovarian Cancer
Cervical Cancer
Breast Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Paclitaxel and Docetaxel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Paclitaxel and Docetaxel in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Paclitaxel and Docetaxel Market Overview
1.1 Product Overview and Scope of Paclitaxel and Docetaxel
1.2 Paclitaxel and Docetaxel Segment by Type
1.2.1 Global Paclitaxel and Docetaxel Market Value Comparison by Type (2024-2030)
1.2.2 Paclitaxel
1.2.3 Docetaxel
1.3 Paclitaxel and Docetaxel Segment by Application
1.3.1 Global Paclitaxel and Docetaxel Market Value by Application: (2024-2030)
1.3.2 Ovarian Cancer
1.3.3 Cervical Cancer
1.3.4 Breast Cancer
1.3.5 Others
1.4 Global Paclitaxel and Docetaxel Market Size Estimates and Forecasts
1.4.1 Global Paclitaxel and Docetaxel Revenue 2019-2030
1.4.2 Global Paclitaxel and Docetaxel Sales 2019-2030
1.4.3 Global Paclitaxel and Docetaxel Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Paclitaxel and Docetaxel Market Competition by Manufacturers
2.1 Global Paclitaxel and Docetaxel Sales Market Share by Manufacturers (2019-2024)
2.2 Global Paclitaxel and Docetaxel Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Paclitaxel and Docetaxel Average Price by Manufacturers (2019-2024)
2.4 Global Paclitaxel and Docetaxel Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Paclitaxel and Docetaxel, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Paclitaxel and Docetaxel, Product Type & Application
2.7 Paclitaxel and Docetaxel Market Competitive Situation and Trends
2.7.1 Paclitaxel and Docetaxel Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Paclitaxel and Docetaxel Players Market Share by Revenue
2.7.3 Global Paclitaxel and Docetaxel Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Paclitaxel and Docetaxel Retrospective Market Scenario by Region
3.1 Global Paclitaxel and Docetaxel Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Paclitaxel and Docetaxel Global Paclitaxel and Docetaxel Sales by Region: 2019-2030
3.2.1 Global Paclitaxel and Docetaxel Sales by Region: 2019-2024
3.2.2 Global Paclitaxel and Docetaxel Sales by Region: 2025-2030
3.3 Global Paclitaxel and Docetaxel Global Paclitaxel and Docetaxel Revenue by Region: 2019-2030
3.3.1 Global Paclitaxel and Docetaxel Revenue by Region: 2019-2024
3.3.2 Global Paclitaxel and Docetaxel Revenue by Region: 2025-2030
3.4 North America Paclitaxel and Docetaxel Market Facts & Figures by Country
3.4.1 North America Paclitaxel and Docetaxel Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Paclitaxel and Docetaxel Sales by Country (2019-2030)
3.4.3 North America Paclitaxel and Docetaxel Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Paclitaxel and Docetaxel Market Facts & Figures by Country
3.5.1 Europe Paclitaxel and Docetaxel Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Paclitaxel and Docetaxel Sales by Country (2019-2030)
3.5.3 Europe Paclitaxel and Docetaxel Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Paclitaxel and Docetaxel Market Facts & Figures by Country
3.6.1 Asia Pacific Paclitaxel and Docetaxel Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Paclitaxel and Docetaxel Sales by Country (2019-2030)
3.6.3 Asia Pacific Paclitaxel and Docetaxel Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Paclitaxel and Docetaxel Market Facts & Figures by Country
3.7.1 Latin America Paclitaxel and Docetaxel Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Paclitaxel and Docetaxel Sales by Country (2019-2030)
3.7.3 Latin America Paclitaxel and Docetaxel Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Paclitaxel and Docetaxel Market Facts & Figures by Country
3.8.1 Middle East and Africa Paclitaxel and Docetaxel Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Paclitaxel and Docetaxel Sales by Country (2019-2030)
3.8.3 Middle East and Africa Paclitaxel and Docetaxel Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Paclitaxel and Docetaxel Sales by Type (2019-2030)
4.1.1 Global Paclitaxel and Docetaxel Sales by Type (2019-2024)
4.1.2 Global Paclitaxel and Docetaxel Sales by Type (2025-2030)
4.1.3 Global Paclitaxel and Docetaxel Sales Market Share by Type (2019-2030)
4.2 Global Paclitaxel and Docetaxel Revenue by Type (2019-2030)
4.2.1 Global Paclitaxel and Docetaxel Revenue by Type (2019-2024)
4.2.2 Global Paclitaxel and Docetaxel Revenue by Type (2025-2030)
4.2.3 Global Paclitaxel and Docetaxel Revenue Market Share by Type (2019-2030)
4.3 Global Paclitaxel and Docetaxel Price by Type (2019-2030)
5 Segment by Application
5.1 Global Paclitaxel and Docetaxel Sales by Application (2019-2030)
5.1.1 Global Paclitaxel and Docetaxel Sales by Application (2019-2024)
5.1.2 Global Paclitaxel and Docetaxel Sales by Application (2025-2030)
5.1.3 Global Paclitaxel and Docetaxel Sales Market Share by Application (2019-2030)
5.2 Global Paclitaxel and Docetaxel Revenue by Application (2019-2030)
5.2.1 Global Paclitaxel and Docetaxel Revenue by Application (2019-2024)
5.2.2 Global Paclitaxel and Docetaxel Revenue by Application (2025-2030)
5.2.3 Global Paclitaxel and Docetaxel Revenue Market Share by Application (2019-2030)
5.3 Global Paclitaxel and Docetaxel Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Phyton
6.1.1 Phyton Corporation Information
6.1.2 Phyton Description and Business Overview
6.1.3 Phyton Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Phyton Paclitaxel and Docetaxel Product Portfolio
6.1.5 Phyton Recent Developments/Updates
6.2 ScinoPharm
6.2.1 ScinoPharm Corporation Information
6.2.2 ScinoPharm Description and Business Overview
6.2.3 ScinoPharm Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2019-2024)
6.2.4 ScinoPharm Paclitaxel and Docetaxel Product Portfolio
6.2.5 ScinoPharm Recent Developments/Updates
6.3 Novasep
6.3.1 Novasep Corporation Information
6.3.2 Novasep Description and Business Overview
6.3.3 Novasep Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novasep Paclitaxel and Docetaxel Product Portfolio
6.3.5 Novasep Recent Developments/Updates
6.4 Samyang
6.4.1 Samyang Corporation Information
6.4.2 Samyang Description and Business Overview
6.4.3 Samyang Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Samyang Paclitaxel and Docetaxel Product Portfolio
6.4.5 Samyang Recent Developments/Updates
6.5 Polymed
6.5.1 Polymed Corporation Information
6.5.2 Polymed Description and Business Overview
6.5.3 Polymed Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Polymed Paclitaxel and Docetaxel Product Portfolio
6.5.5 Polymed Recent Developments/Updates
6.6 TAPI (Teva)
6.6.1 TAPI (Teva) Corporation Information
6.6.2 TAPI (Teva) Description and Business Overview
6.6.3 TAPI (Teva) Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2019-2024)
6.6.4 TAPI (Teva) Paclitaxel and Docetaxel Product Portfolio
6.6.5 TAPI (Teva) Recent Developments/Updates
6.7 Fresenius-kabi
6.6.1 Fresenius-kabi Corporation Information
6.6.2 Fresenius-kabi Description and Business Overview
6.6.3 Fresenius-kabi Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fresenius-kabi Paclitaxel and Docetaxel Product Portfolio
6.7.5 Fresenius-kabi Recent Developments/Updates
6.8 Huiang biopharma
6.8.1 Huiang biopharma Corporation Information
6.8.2 Huiang biopharma Description and Business Overview
6.8.3 Huiang biopharma Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Huiang biopharma Paclitaxel and Docetaxel Product Portfolio
6.8.5 Huiang biopharma Recent Developments/Updates
6.9 Southpharma
6.9.1 Southpharma Corporation Information
6.9.2 Southpharma Description and Business Overview
6.9.3 Southpharma Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Southpharma Paclitaxel and Docetaxel Product Portfolio
6.9.5 Southpharma Recent Developments/Updates
6.10 Yunnan Hande
6.10.1 Yunnan Hande Corporation Information
6.10.2 Yunnan Hande Description and Business Overview
6.10.3 Yunnan Hande Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Yunnan Hande Paclitaxel and Docetaxel Product Portfolio
6.10.5 Yunnan Hande Recent Developments/Updates
6.11 Hainan Yew Pharm
6.11.1 Hainan Yew Pharm Corporation Information
6.11.2 Hainan Yew Pharm Paclitaxel and Docetaxel Description and Business Overview
6.11.3 Hainan Yew Pharm Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hainan Yew Pharm Paclitaxel and Docetaxel Product Portfolio
6.11.5 Hainan Yew Pharm Recent Developments/Updates
6.12 Jiangsu Yew Biotechnology
6.12.1 Jiangsu Yew Biotechnology Corporation Information
6.12.2 Jiangsu Yew Biotechnology Paclitaxel and Docetaxel Description and Business Overview
6.12.3 Jiangsu Yew Biotechnology Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Jiangsu Yew Biotechnology Paclitaxel and Docetaxel Product Portfolio
6.12.5 Jiangsu Yew Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Paclitaxel and Docetaxel Industry Chain Analysis
7.2 Paclitaxel and Docetaxel Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Paclitaxel and Docetaxel Production Mode & Process
7.4 Paclitaxel and Docetaxel Sales and Marketing
7.4.1 Paclitaxel and Docetaxel Sales Channels
7.4.2 Paclitaxel and Docetaxel Distributors
7.5 Paclitaxel and Docetaxel Customers
8 Paclitaxel and Docetaxel Market Dynamics
8.1 Paclitaxel and Docetaxel Industry Trends
8.2 Paclitaxel and Docetaxel Market Drivers
8.3 Paclitaxel and Docetaxel Market Challenges
8.4 Paclitaxel and Docetaxel Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Paclitaxel and Docetaxel Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Paclitaxel and Docetaxel Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Paclitaxel and Docetaxel Market Competitive Situation by Manufacturers in 2023
Table 4. Global Paclitaxel and Docetaxel Sales (Kiloton) of Key Manufacturers (2019-2024)
Table 5. Global Paclitaxel and Docetaxel Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Paclitaxel and Docetaxel Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Paclitaxel and Docetaxel Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Paclitaxel and Docetaxel Average Price (US$/Ton) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Paclitaxel and Docetaxel, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Paclitaxel and Docetaxel, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Paclitaxel and Docetaxel, Product Type & Application
Table 12. Global Key Manufacturers of Paclitaxel and Docetaxel, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Paclitaxel and Docetaxel by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paclitaxel and Docetaxel as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Paclitaxel and Docetaxel Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Paclitaxel and Docetaxel Sales by Region (2019-2024) & (Kiloton)
Table 18. Global Paclitaxel and Docetaxel Sales Market Share by Region (2019-2024)
Table 19. Global Paclitaxel and Docetaxel Sales by Region (2025-2030) & (Kiloton)
Table 20. Global Paclitaxel and Docetaxel Sales Market Share by Region (2025-2030)
Table 21. Global Paclitaxel and Docetaxel Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Paclitaxel and Docetaxel Revenue Market Share by Region (2019-2024)
Table 23. Global Paclitaxel and Docetaxel Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Paclitaxel and Docetaxel Revenue Market Share by Region (2025-2030)
Table 25. North America Paclitaxel and Docetaxel Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Paclitaxel and Docetaxel Sales by Country (2019-2024) & (Kiloton)
Table 27. North America Paclitaxel and Docetaxel Sales by Country (2025-2030) & (Kiloton)
Table 28. North America Paclitaxel and Docetaxel Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Paclitaxel and Docetaxel Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Paclitaxel and Docetaxel Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Paclitaxel and Docetaxel Sales by Country (2019-2024) & (Kiloton)
Table 32. Europe Paclitaxel and Docetaxel Sales by Country (2025-2030) & (Kiloton)
Table 33. Europe Paclitaxel and Docetaxel Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Paclitaxel and Docetaxel Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Paclitaxel and Docetaxel Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Paclitaxel and Docetaxel Sales by Region (2019-2024) & (Kiloton)
Table 37. Asia Pacific Paclitaxel and Docetaxel Sales by Region (2025-2030) & (Kiloton)
Table 38. Asia Pacific Paclitaxel and Docetaxel Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Paclitaxel and Docetaxel Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Paclitaxel and Docetaxel Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Paclitaxel and Docetaxel Sales by Country (2019-2024) & (Kiloton)
Table 42. Latin America Paclitaxel and Docetaxel Sales by Country (2025-2030) & (Kiloton)
Table 43. Latin America Paclitaxel and Docetaxel Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Paclitaxel and Docetaxel Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Paclitaxel and Docetaxel Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Paclitaxel and Docetaxel Sales by Country (2019-2024) & (Kiloton)
Table 47. Middle East & Africa Paclitaxel and Docetaxel Sales by Country (2025-2030) & (Kiloton)
Table 48. Middle East & Africa Paclitaxel and Docetaxel Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Paclitaxel and Docetaxel Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Paclitaxel and Docetaxel Sales (Kiloton) by Type (2019-2024)
Table 51. Global Paclitaxel and Docetaxel Sales (Kiloton) by Type (2025-2030)
Table 52. Global Paclitaxel and Docetaxel Sales Market Share by Type (2019-2024)
Table 53. Global Paclitaxel and Docetaxel Sales Market Share by Type (2025-2030)
Table 54. Global Paclitaxel and Docetaxel Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Paclitaxel and Docetaxel Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Paclitaxel and Docetaxel Revenue Market Share by Type (2019-2024)
Table 57. Global Paclitaxel and Docetaxel Revenue Market Share by Type (2025-2030)
Table 58. Global Paclitaxel and Docetaxel Price (US$/Ton) by Type (2019-2024)
Table 59. Global Paclitaxel and Docetaxel Price (US$/Ton) by Type (2025-2030)
Table 60. Global Paclitaxel and Docetaxel Sales (Kiloton) by Application (2019-2024)
Table 61. Global Paclitaxel and Docetaxel Sales (Kiloton) by Application (2025-2030)
Table 62. Global Paclitaxel and Docetaxel Sales Market Share by Application (2019-2024)
Table 63. Global Paclitaxel and Docetaxel Sales Market Share by Application (2025-2030)
Table 64. Global Paclitaxel and Docetaxel Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Paclitaxel and Docetaxel Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Paclitaxel and Docetaxel Revenue Market Share by Application (2019-2024)
Table 67. Global Paclitaxel and Docetaxel Revenue Market Share by Application (2025-2030)
Table 68. Global Paclitaxel and Docetaxel Price (US$/Ton) by Application (2019-2024)
Table 69. Global Paclitaxel and Docetaxel Price (US$/Ton) by Application (2025-2030)
Table 70. Phyton Corporation Information
Table 71. Phyton Description and Business Overview
Table 72. Phyton Paclitaxel and Docetaxel Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 73. Phyton Paclitaxel and Docetaxel Product
Table 74. Phyton Recent Developments/Updates
Table 75. ScinoPharm Corporation Information
Table 76. ScinoPharm Description and Business Overview
Table 77. ScinoPharm Paclitaxel and Docetaxel Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 78. ScinoPharm Paclitaxel and Docetaxel Product
Table 79. ScinoPharm Recent Developments/Updates
Table 80. Novasep Corporation Information
Table 81. Novasep Description and Business Overview
Table 82. Novasep Paclitaxel and Docetaxel Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 83. Novasep Paclitaxel and Docetaxel Product
Table 84. Novasep Recent Developments/Updates
Table 85. Samyang Corporation Information
Table 86. Samyang Description and Business Overview
Table 87. Samyang Paclitaxel and Docetaxel Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 88. Samyang Paclitaxel and Docetaxel Product
Table 89. Samyang Recent Developments/Updates
Table 90. Polymed Corporation Information
Table 91. Polymed Description and Business Overview
Table 92. Polymed Paclitaxel and Docetaxel Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 93. Polymed Paclitaxel and Docetaxel Product
Table 94. Polymed Recent Developments/Updates
Table 95. TAPI (Teva) Corporation Information
Table 96. TAPI (Teva) Description and Business Overview
Table 97. TAPI (Teva) Paclitaxel and Docetaxel Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 98. TAPI (Teva) Paclitaxel and Docetaxel Product
Table 99. TAPI (Teva) Recent Developments/Updates
Table 100. Fresenius-kabi Corporation Information
Table 101. Fresenius-kabi Description and Business Overview
Table 102. Fresenius-kabi Paclitaxel and Docetaxel Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 103. Fresenius-kabi Paclitaxel and Docetaxel Product
Table 104. Fresenius-kabi Recent Developments/Updates
Table 105. Huiang biopharma Corporation Information
Table 106. Huiang biopharma Description and Business Overview
Table 107. Huiang biopharma Paclitaxel and Docetaxel Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 108. Huiang biopharma Paclitaxel and Docetaxel Product
Table 109. Huiang biopharma Recent Developments/Updates
Table 110. Southpharma Corporation Information
Table 111. Southpharma Description and Business Overview
Table 112. Southpharma Paclitaxel and Docetaxel Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 113. Southpharma Paclitaxel and Docetaxel Product
Table 114. Southpharma Recent Developments/Updates
Table 115. Yunnan Hande Corporation Information
Table 116. Yunnan Hande Description and Business Overview
Table 117. Yunnan Hande Paclitaxel and Docetaxel Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 118. Yunnan Hande Paclitaxel and Docetaxel Product
Table 119. Yunnan Hande Recent Developments/Updates
Table 120. Hainan Yew Pharm Corporation Information
Table 121. Hainan Yew Pharm Description and Business Overview
Table 122. Hainan Yew Pharm Paclitaxel and Docetaxel Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 123. Hainan Yew Pharm Paclitaxel and Docetaxel Product
Table 124. Hainan Yew Pharm Recent Developments/Updates
Table 125. Jiangsu Yew Biotechnology Corporation Information
Table 126. Jiangsu Yew Biotechnology Description and Business Overview
Table 127. Jiangsu Yew Biotechnology Paclitaxel and Docetaxel Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 128. Jiangsu Yew Biotechnology Paclitaxel and Docetaxel Product
Table 129. Jiangsu Yew Biotechnology Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Paclitaxel and Docetaxel Distributors List
Table 133. Paclitaxel and Docetaxel Customers List
Table 134. Paclitaxel and Docetaxel Market Trends
Table 135. Paclitaxel and Docetaxel Market Drivers
Table 136. Paclitaxel and Docetaxel Market Challenges
Table 137. Paclitaxel and Docetaxel Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Paclitaxel and Docetaxel
Figure 2. Global Paclitaxel and Docetaxel Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Paclitaxel and Docetaxel Market Share by Type in 2023 & 2030
Figure 4. Paclitaxel Product Picture
Figure 5. Docetaxel Product Picture
Figure 6. Global Paclitaxel and Docetaxel Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Paclitaxel and Docetaxel Market Share by Application in 2023 & 2030
Figure 8. Ovarian Cancer
Figure 9. Cervical Cancer
Figure 10. Breast Cancer
Figure 11. Others
Figure 12. Global Paclitaxel and Docetaxel Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Paclitaxel and Docetaxel Market Size (2019-2030) & (US$ Million)
Figure 14. Global Paclitaxel and Docetaxel Sales (2019-2030) & (Kiloton)
Figure 15. Global Paclitaxel and Docetaxel Average Price (US$/Ton) & (2019-2030)
Figure 16. Paclitaxel and Docetaxel Report Years Considered
Figure 17. Paclitaxel and Docetaxel Sales Share by Manufacturers in 2023
Figure 18. Global Paclitaxel and Docetaxel Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Paclitaxel and Docetaxel Players: Market Share by Revenue in 2023
Figure 20. Paclitaxel and Docetaxel Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Paclitaxel and Docetaxel Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Paclitaxel and Docetaxel Sales Market Share by Country (2019-2030)
Figure 23. North America Paclitaxel and Docetaxel Revenue Market Share by Country (2019-2030)
Figure 24. United States Paclitaxel and Docetaxel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Paclitaxel and Docetaxel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Paclitaxel and Docetaxel Sales Market Share by Country (2019-2030)
Figure 27. Europe Paclitaxel and Docetaxel Revenue Market Share by Country (2019-2030)
Figure 28. Germany Paclitaxel and Docetaxel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Paclitaxel and Docetaxel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Paclitaxel and Docetaxel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Paclitaxel and Docetaxel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Paclitaxel and Docetaxel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Paclitaxel and Docetaxel Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Paclitaxel and Docetaxel Revenue Market Share by Region (2019-2030)
Figure 35. China Paclitaxel and Docetaxel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Paclitaxel and Docetaxel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Paclitaxel and Docetaxel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Paclitaxel and Docetaxel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Paclitaxel and Docetaxel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Paclitaxel and Docetaxel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Paclitaxel and Docetaxel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Paclitaxel and Docetaxel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Paclitaxel and Docetaxel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Paclitaxel and Docetaxel Sales Market Share by Country (2019-2030)
Figure 45. Latin America Paclitaxel and Docetaxel Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Paclitaxel and Docetaxel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Paclitaxel and Docetaxel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Paclitaxel and Docetaxel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Paclitaxel and Docetaxel Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Paclitaxel and Docetaxel Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Paclitaxel and Docetaxel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Paclitaxel and Docetaxel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Paclitaxel and Docetaxel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Paclitaxel and Docetaxel by Type (2019-2030)
Figure 55. Global Revenue Market Share of Paclitaxel and Docetaxel by Type (2019-2030)
Figure 56. Global Paclitaxel and Docetaxel Price (US$/Ton) by Type (2019-2030)
Figure 57. Global Sales Market Share of Paclitaxel and Docetaxel by Application (2019-2030)
Figure 58. Global Revenue Market Share of Paclitaxel and Docetaxel by Application (2019-2030)
Figure 59. Global Paclitaxel and Docetaxel Price (US$/Ton) by Application (2019-2030)
Figure 60. Paclitaxel and Docetaxel Value Chain
Figure 61. Paclitaxel and Docetaxel Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
